NCT03771040View on ClinicalTrials.gov

Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels

PHASE3CompletedINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Asthma
Interventions
DRUG

Masitinib

DRUG

Placebo

Trial Locations (5)

93586

Sarawak General Hospital, Kuching

Unknown

Centro Respiratorio Quilmes, Buenos Aires

Clínica Universidad de los Andes, Miraflores

The Philippine Heart Center, Quezon City

03680

National institute of phthisiology and pulmonology named after F.G. Yanovsky NAMS of Ukraine, Kiev

Sponsors

Lead Sponsor

AB Science
All Listed Sponsors
lead

AB Science

INDUSTRY